Labros Meimetis
Overview
Explore the profile of Labros Meimetis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gunaratne G, Gallant J, Ott K, Broome P, Celada S, West J, et al.
bioRxiv
. 2025 Jan;
PMID: 39868181
Cancer-associated fibroblasts (CAFs) in the stroma of solid tumors promote an immunosuppressive tumor microenvironment (TME) that drives resistance to therapies. The expression of the protease fibroblast activation protein (FAP) on...
2.
Pollard-Kerning A, Li K, Li Y, Ahn S, Wang M, Akoglu M, et al.
ACS Infect Dis
. 2024 Oct;
10(11):3765-3774.
PMID: 39432749
Deep-seated bacterial infections are difficult to detect and diagnose due to the lack of specific clinical imaging modalities. Therefore, the bacteria-specific positron emission tomography radiotracer 2-[F]fluoro-4-nitrobenzoic acid ([F]FNB) was developed,...
3.
Sharifi M, Shi Y, Chrostek M, Callahan S, Shang T, Berg T, et al.
JCI Insight
. 2024 Sep;
9(18).
PMID: 39315546
Therapies against cell-surface targets (CSTs) represent an emerging treatment class in solid malignancies. However, high-throughput investigations of CST expression across cancer types have been reliant on data sets of mostly...
4.
Gallant J, Hintz H, Gunaratne G, Breneman M, Recchia E, West J, et al.
Cancer Res Commun
. 2024 May;
4(6):1481-1494.
PMID: 38747612
Significance: The direct elimination of FAP-expressing CAFs disrupts the cross-talk with cancer cells leading to a proinflammatory response and alterations in the immune microenvironment and antitumor immune response.
5.
Smilowicz D, Schlyer D, Boros E, Meimetis L
Mol Pharm
. 2022 Jul;
19(9):3217-3227.
PMID: 35895995
An immunosuppressive tumor microenvironment and tumor heterogeneity have led to the resilience of metastatic castrate resistant prostate cancer (mCRPC) to current treatments. To address these challenges, we developed and evaluated...
6.
Li Y, Daryaee F, Yoon G, Noh D, Smith-Jones P, Si Y, et al.
ACS Infect Dis
. 2020 Jul;
6(8):2249-2259.
PMID: 32672928
Deep-seated bacterial infections caused by pathogens such as are difficult to diagnose and treat and are thus a major threat to human health. In previous work we demonstrated that positron...
7.
Cho I, Meimetis L, Belding L, Katz M, Dudding T, Britton R
Beilstein J Org Chem
. 2011 Nov;
7:1315-22.
PMID: 22043241
A variety of ortho,ortho'-disubstituted hydrobenzoin derivatives are readily accessible through a directed ortho,ortho'-dimetalation strategy in which the alcohol functions in hydrobenzoin are deprotonated by n-BuLi and the resulting lithium benzyl...
8.
Cho I, Meimetis L, Britton R
Org Lett
. 2009 Mar;
11(9):1903-6.
PMID: 19326895
A bidirectional ortho metalation of the readily available chiral diol hydrobenzoin has been developed that provides direct access to new ortho-functionalized hydrobenzoin derivatives. This one-pot procedure should broaden the utility...